Learning to Donate
LEARN-DO aims to enhance blood donor recruitment through an engaging knowledge intervention targeting potential donors and blood agencies, addressing barriers and motivators to increase participation.
Projectdetails
Background
Without blood donors, there are no blood products to transfuse and no plasma for pharmaceutical drug production. Four million patients are annually treated with blood-derived products in Europe alone, given by voluntary donors. Yet, as little as 2-3% of the population is registered as blood donors, and donor numbers have been decreasing over the last decades.
At the same time, the demand for specific blood products is increasing. Hence, it is crucial that a country’s donor pool is sufficient to ensure access to every needed blood type and plasma product. Targeted recruitment and retention of donors is vital to meet these demands.
Aim
LEARN-DO intends to develop and market a fun and interactive knowledge intervention to stimulate key motivators and overcome key barriers for individuals to become blood donors.
Approach
We target two main stakeholder groups with this intervention:
- Individuals (children and adults) who can be potential future donors.
- Blood collection agencies that need to recruit future donors to meet the demands for blood products.
We propose three installation elements that manipulate key barriers and motivators of blood donation:
- A Donor Picture Pillar that provides information about blood donation and shows patient and donor stories.
- A "Donation Experience" to decrease fears and psychological distance towards blood donation.
- A Conversation Couch to stimulate talking about donation among participants.
Organisation and Impact
The project is organised in four work packages (WP). The overarching project management (WP1, led by the PI at the host institute) will ensure that the impact proposition will include all scientific (WP2), technical/education (WP3), and business (WP4) aspects.
LEARN-DO can thoroughly change the recruitment of future donors and improve the recruitment strategy of blood collection agencies by making them more evidence-based, fun, interactive, and targeted to specific groups, including families and members from ethnic minorities.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-3-2024 |
Einddatum | 31-8-2025 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- STICHTING VUpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Explore Your Brain 2.0: a maximally effective, usable and scalable growth mindset intervention to break through adolescents’ declining rates of motivation and school achievementsThis project aims to enhance and scale the Explore Your Brain (EYB 2.0) intervention to improve high school students' motivation and resilience through a growth mindset approach. | ERC Proof of... | € 150.000 | 2024 | Details |
Next-generation red cell analysers for blood-banking, transfusion medicine, and haematological diagnosisDeveloping a single-cell oxygen saturation imaging method to measure O2 release from red blood cells, aiming to enhance blood quality assessment and clinical applications in transfusion medicine. | ERC Proof of... | € 150.000 | 2024 | Details |
Cocreating Actions to Improve Rationality in the health systemThis project aims to enhance health equity by co-creating community-led actions addressing psychological well-being, cardiovascular health, and antimicrobial resistance, reducing reliance on individual-level solutions. | ERC Consolid... | € 1.998.750 | 2024 | Details |
Drug DELIvery to the brain via CHOroid Plexus targetingThis project aims to explore the blood-CSF barrier as a novel route for delivering therapeutics to the brain, potentially enhancing treatment strategies for CNS disorders. | ERC Consolid... | € 1.999.756 | 2024 | Details |
How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantationRESTART aims to enhance survival in pediatric HSCT by using multiomics to characterize human HSPC regeneration and identify predictors of adverse outcomes. | ERC Starting... | € 1.500.000 | 2024 | Details |
Explore Your Brain 2.0: a maximally effective, usable and scalable growth mindset intervention to break through adolescents’ declining rates of motivation and school achievements
This project aims to enhance and scale the Explore Your Brain (EYB 2.0) intervention to improve high school students' motivation and resilience through a growth mindset approach.
Next-generation red cell analysers for blood-banking, transfusion medicine, and haematological diagnosis
Developing a single-cell oxygen saturation imaging method to measure O2 release from red blood cells, aiming to enhance blood quality assessment and clinical applications in transfusion medicine.
Cocreating Actions to Improve Rationality in the health system
This project aims to enhance health equity by co-creating community-led actions addressing psychological well-being, cardiovascular health, and antimicrobial resistance, reducing reliance on individual-level solutions.
Drug DELIvery to the brain via CHOroid Plexus targeting
This project aims to explore the blood-CSF barrier as a novel route for delivering therapeutics to the brain, potentially enhancing treatment strategies for CNS disorders.
How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantation
RESTART aims to enhance survival in pediatric HSCT by using multiomics to characterize human HSPC regeneration and identify predictors of adverse outcomes.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Een schaalbaar en patiëntvriendelijk alternatief voor veneuze prikmethode voor bloedafnameHet project ontwikkelt een bloedsampler om laagdrempelig bloedafname voor preventieve zorg te faciliteren, gericht op het verbeteren van doelmatigheid en het verlichten van personeelstekorten. | Mkb-innovati... | € 20.000 | 2023 | Details |
Personalized PostYourLabLabonovum ontwikkelt met het PostYourLab platform een gepersonaliseerd gezondheidsprofiel met AI-analyse van bloedtesten, gericht op betere inzichten en efficiëntere artsconsulten. | Mkb-innovati... | € 20.000 | 2022 | Details |
De eerste circulair geproduceerde bloedafnamebuisLabonovum ontwikkelt Hem-Col-Circ, een circulaire bloedafnameoplossing die de medische afvalimpact vermindert door innovatieve materialen en processen te onderzoeken voor duurzame bloedafname. | Mkb-innovati... | € 20.000 | 2021 | Details |
An innovative filtration system to improve the coagulation properties of plasma units to treat patients with massive bleedingPlasFree is developing ClearPlasma™, a filtration system that extracts plasminogen to improve haemorrhage treatment and reduce plasma unit requirements, aiming for clinical validation and global impact. | EIC Accelerator | € 1.279.184 | 2022 | Details |
Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactorThe project aims to upscale ex vivo production of universal platelets using innovative technologies to meet rising demand and ensure compatibility for patients with transfusion reactions. | EIC Transition | € 1.798.152 | 2022 | Details |
Een schaalbaar en patiëntvriendelijk alternatief voor veneuze prikmethode voor bloedafname
Het project ontwikkelt een bloedsampler om laagdrempelig bloedafname voor preventieve zorg te faciliteren, gericht op het verbeteren van doelmatigheid en het verlichten van personeelstekorten.
Personalized PostYourLab
Labonovum ontwikkelt met het PostYourLab platform een gepersonaliseerd gezondheidsprofiel met AI-analyse van bloedtesten, gericht op betere inzichten en efficiëntere artsconsulten.
De eerste circulair geproduceerde bloedafnamebuis
Labonovum ontwikkelt Hem-Col-Circ, een circulaire bloedafnameoplossing die de medische afvalimpact vermindert door innovatieve materialen en processen te onderzoeken voor duurzame bloedafname.
An innovative filtration system to improve the coagulation properties of plasma units to treat patients with massive bleeding
PlasFree is developing ClearPlasma™, a filtration system that extracts plasminogen to improve haemorrhage treatment and reduce plasma unit requirements, aiming for clinical validation and global impact.
Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor
The project aims to upscale ex vivo production of universal platelets using innovative technologies to meet rising demand and ensure compatibility for patients with transfusion reactions.